citat
fouchier
ram
studi
influenza
viru
transmiss
ferret
public
health
risk
revisit
mbio
l
ipsitch
inglesbi
recent
estim
potenti
public
health
risk
associ
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
lead
conclud
research
riski
conduct
author
public
estim
probabl
laboratoryacquir
infect
lai
onward
transmiss
virus
investig
well
potenti
consequ
public
health
event
occur
given
weight
assign
risk
estim
import
potenti
pitfal
underli
assumpt
analys
rigor
scrutin
importantli
publish
estim
base
histor
data
take
account
numer
risk
reduct
measur
place
laboratori
research
conduct
provid
critic
apprais
publish
work
discuss
challeng
modifi
estim
base
specif
condit
work
perform
properti
virus
investig
outcom
risk
assess
chang
seriou
risk
neglig
risk
human
environ
consequ
balanc
debat
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
warrant
particular
given
substanti
public
health
benefit
assign
type
research
initi
calcul
potenti
risk
associ
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
use
report
select
agent
theft
loss
releas
collect
us
center
diseas
control
prevent
cdc
calcul
probabl
occurr
lai
although
report
limit
provid
recent
account
lai
unit
state
probabl
reflect
current
state
art
biosafeti
biosecur
practic
better
older
studi
laboratori
incid
eg
consequ
implement
us
select
agent
program
best
practic
develop
biosafeti
biosecur
gener
last
decad
lai
total
report
us
cdc
occur
biosafeti
level
facil
period
averag
individu
per
year
access
select
agent
averag
laboratori
per
year
thu
total
laboratoryyear
personyear
followup
data
probabl
occurr
lai
condit
calcul
per
laboratoryyear
per
personyear
estim
howev
take
account
specif
pathogen
type
research
set
crucial
work
practic
eg
virolog
microbiolog
laboratori
differ
biosafeti
laboratori
uniqu
research
facil
experi
conduct
therefor
apprais
target
risk
assess
plan
studi
scrutin
experi
start
note
import
none
lai
report
us
cdc
involv
virus
risk
lai
associ
work
viral
pathogen
thu
estim
less
per
per
laboratoryyear
less
per
per
personyear
unfortun
report
henkel
et
al
specifi
mani
laboratoryyear
personyear
relat
facil
versu
facil
thu
use
denomin
yield
underestim
true
probabl
lai
condit
discuss
previous
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
perform
facil
condit
specif
design
purpos
studi
ordinari
laboratori
includ
diagnost
laboratori
work
perform
openfront
class
biosafeti
cabinet
direct
airflow
aim
protect
environ
releas
pathogen
protect
laboratori
worker
exposur
contrari
ordinari
condit
work
virus
vivo
vitro
experiment
work
influenza
viru
transmiss
erasmu
mc
facil
carri
class
isol
class
biosafeti
cabinet
airtight
box
neg
pressur
pa
ensur
inward
flow
case
leakag
handl
done
airtight
glove
fit
front
cabinet
air
releas
class
unit
filter
high
effici
particul
air
hepa
filter
leav
directli
via
facil
ventil
system
via
hepa
filter
author
experienc
personnel
receiv
extens
train
access
facil
anim
handl
personnel
alway
work
pair
reduc
chanc
human
error
although
laboratori
consid
clean
experi
conduct
close
class
cabinet
isol
special
person
protect
equip
includ
laboratori
suit
glove
class
filter
face
piec
facemask
use
personnel
vaccin
homolog
vaccin
equip
facil
monitor
electron
alarm
system
employ
ensur
worker
enter
facil
equip
malfunct
personnel
instruct
train
act
case
incid
handl
upon
consult
senior
staff
member
clinic
microbiologist
institut
biosafeti
offic
facil
manag
antivir
drug
oseltamivir
zanamivir
use
immedi
event
incid
occur
everi
incid
laboratori
follow
action
prevent
incid
happen
facil
personnel
procedur
inspect
us
cdc
everi
year
agreement
us
select
agent
regul
oversea
laboratori
dutch
govern
inspecti
leefomgev
en
transport
ilt
inspect
biosafeti
condit
erasmu
mc
facil
thu
extend
well
beyond
normal
condit
work
virus
number
biosafeti
measur
consid
probabl
lai
infer
us
cdc
report
unfortun
exact
number
effect
individu
biosafeti
measur
avail
howev
reason
assum
effect
physic
separ
personnel
virus
work
use
class
isol
unit
class
biosafeti
cabinet
use
personnel
protect
equip
extens
train
program
use
experienc
personnel
applic
twoperson
rule
reduc
human
error
anim
experi
would
yield
decreas
probabl
lai
although
magnitud
increas
safeti
known
assum
least
factor
use
risk
analysi
done
other
assumpt
reduc
risk
probabl
lai
erasmu
mc
facil
would
reduc
per
personyear
quantit
risk
assess
perform
upon
request
us
govern
challeng
task
better
quantit
assess
effect
biosafeti
measur
individu
laboratori
yield
exact
number
instead
conserv
estim
use
vaccin
laboratori
personnel
homolog
viru
investig
produc
anoth
layer
safeti
result
risk
mitig
given
gener
accept
efficaci
influenza
vaccin
laboratoryconfirm
influenza
healthi
adult
vaccin
reduc
probabl
lai
result
viral
escap
per
personyear
valu
almost
certainli
underestim
number
taken
gener
popul
studi
includ
individu
impair
immun
nonexact
match
vaccin
antigen
circul
virus
import
note
antibodi
titer
vaccin
laboratori
worker
high
geometr
mean
titer
rang
compar
titer
gener
accept
protect
season
influenza
individu
revaccin
antibodi
titer
decreas
consequ
monitor
equip
electron
visual
inspect
potenti
exposur
viru
unlik
go
unnot
upon
potenti
exposur
personnel
receiv
oseltamivir
treatment
upon
consult
variou
specialist
indic
earli
treatment
drug
report
efficaci
human
influenza
viru
infect
avian
influenza
viru
infect
import
note
virus
studi
erasmu
mc
facil
evalu
sensit
oseltamivir
immedi
treatment
laboratori
personnel
oseltamivir
upon
potenti
exposur
viru
thu
expect
reduc
probabl
lai
per
personyear
given
averag
efficaci
prevent
laboratoryconfirm
influenza
analysi
conserv
estim
research
perform
transmiss
influenza
virus
via
respiratori
droplet
aerosol
ferret
erasmu
mc
facil
person
access
lai
would
expect
occur
less
frequent
everi
million
year
second
factor
equat
previou
risk
assess
probabl
onward
transmiss
case
lai
previou
studi
use
probabl
onward
transmiss
base
unlimit
spread
pandem
influenza
viru
gener
popul
import
note
onward
transmiss
lai
far
uncommon
case
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
substanti
scientif
justifi
reduct
probabl
onward
transmiss
lai
made
base
abovement
biosafeti
measur
risk
mitig
strategi
place
first
factor
need
consid
laboratori
personnel
acquir
lai
vaccin
homolog
viru
treat
oseltamivir
upon
incid
potenti
exposur
viru
although
vaccin
treatment
may
insuffici
prevent
infect
altogeth
henc
occurr
lai
frequenc
less
everi
million
year
viru
shed
oseltamivirtr
individu
like
reduc
substanti
compar
onward
transmiss
time
spread
influenza
pandem
untreat
immunolog
naiv
individu
assum
conserv
reduct
viru
excret
immun
treat
individu
compar
untreat
immunolog
naiv
individu
rang
probabl
onward
transmiss
case
lai
would
reduc
import
risk
mitig
strategi
reduc
onward
transmiss
upon
potenti
lai
erasmu
mc
polici
dictat
enforc
quarantin
laboratori
personnel
potenti
viru
expos
polici
would
reduc
exposur
nonlaboratori
personnel
one
partner
laboratori
worker
nil
rather
contact
human
adult
would
ordinarili
time
frame
consequ
transmiss
probabl
yield
probabl
onward
transmiss
case
lai
final
factor
consid
calcul
probabl
onward
transmiss
case
lai
basic
reproduct
number
influenza
viru
investig
indic
previou
risk
assess
base
pandem
influenza
viru
howev
laboratori
experi
shown
effici
transmiss
laboratoryderiv
influenza
virus
lower
transmiss
pandem
season
influenza
virus
ferret
could
letter
editor
expect
moreov
given
virus
ferret
adapt
rather
human
adapt
even
extrem
conserv
adjust
transmiss
paramet
factor
would
yield
final
estim
probabl
onward
transmiss
case
lai
multipli
probabl
occurr
lai
probabl
onward
transmiss
case
lai
one
estim
probabl
lai
result
onward
transmiss
would
rang
analysi
estim
research
perform
transmiss
influenza
virus
via
respiratori
droplet
aerosol
ferret
erasmu
mc
facil
person
access
lai
onward
transmiss
would
expect
occur
far
less
frequent
everi
billion
year
probabl
could
assign
term
neglig
given
age
planet
billion
year
previou
work
assum
ferretadapt
avian
influenza
viru
caus
lai
onward
transmiss
could
caus
pandem
attack
rate
deduc
previou
pandem
case
fatal
rate
rang
popul
billion
peopl
thu
lead
million
billion
fatal
howev
consid
attack
rate
case
fatal
rate
magnitud
unrealist
given
avian
influenza
virus
investig
ferret
adapt
rather
human
adapt
unlik
virus
would
spread
effici
human
note
mean
ferret
model
therefor
useless
studi
increas
fundament
knowledg
airborn
viru
transmiss
simpli
mean
thatjust
like
mous
model
use
address
fundament
immunologyw
need
care
valid
result
obtain
anim
extrapol
human
throughout
histori
virolog
scientist
adapt
virus
cell
chicken
embryo
anim
speci
order
yield
virus
increas
replic
properti
specif
host
cell
time
lose
replic
capac
virul
other
exampl
passag
vaccinia
viru
chicken
embryo
fibroblast
yield
modifi
vaccinia
viru
ankara
mva
use
safe
vaccin
vector
passag
measl
viru
mump
viru
rubella
viru
variou
cell
yield
liveattenu
mmr
vaccin
passag
influenza
virus
mice
ferret
egg
yield
vaccin
strain
apr
highli
attenu
human
higher
bound
rang
case
fatal
rate
stem
number
death
record
among
laboratoryconfirm
case
influenza
report
sinc
mild
case
infectionthos
individu
consult
physician
remain
untestedar
record
true
case
fatal
rate
viru
infect
human
unknown
due
intrins
difficulti
associ
serolog
data
estim
number
previous
infect
individu
consensu
incid
infect
southeast
asia
case
fatal
rate
order
magnitud
lower
infer
addit
import
note
fatal
ferret
infect
viru
via
respiratori
droplet
aerosol
occur
contrari
ferret
receiv
larg
dosag
viru
directli
lower
airway
topic
intent
accident
releas
virus
laboratori
involv
influenza
viru
transmiss
studi
import
note
decad
transmiss
studi
pandem
epidem
strain
deriv
pandem
variou
wildtyp
laboratoryadapt
zoonot
virus
subtyp
summar
refer
lai
record
also
record
intent
accident
releas
centuri
research
human
anim
influenza
virus
includ
highli
pathogen
avian
influenza
virus
even
time
biocontain
measur
larg
nonexist
argu
russian
influenza
epidem
result
laboratori
accid
influenza
research
done
condit
limit
biocontain
attenu
wild
type
strain
test
human
know
happen
conclud
viru
escap
laboratori
sinc
natur
influenza
pandem
occur
averag
everi
year
last
centuri
probabl
next
pandem
emerg
natur
order
magnitud
larger
emerg
laboratori
given
recent
summar
immedi
shortterm
benefit
research
influenza
virus
transmit
via
respiratori
droplet
aerosol
ferret
longerterm
aim
fulli
understand
predict
prevent
pandem
combin
extrem
low
risk
human
environ
associ
properli
conduct
experi
conclud
sensibl
accept
restart
research
provid
laboratori
particip
research
adopt
biosafeti
biosecur
condit
compar
current
place
grate
help
friend
colleagu
provid
valuabl
input
support
letter
activ
field
research
influenza
viru
transmiss
via
respiratori
droplet
aerosol
ferret
fund
european
union
niaidnih
inventor
patent
relat
influenza
viru
revers
genet
